“…The aim of this systematic review was to investigate the alterations of MPV in various types of cancer in relation to healthy subjects and to assess the relation of MPV to disease outcomes according to data published from 2010 to 2022. In total, 83 studies with 21,034 participants and 12 different types of cancer were included, i.e., gastric cancer [ 15 , 31 , 32 , 33 , 34 , 35 , 36 , 37 ], colon cancer [ 13 , 19 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 ], esophageal squamous cell carcinoma [ 20 , 47 , 48 , 49 , 50 ], renal cancer [ 18 , 51 , 52 ], breast cancer [ 16 , 53 , 54 , 55 , 56 , 57 , 58 , 59 ], ovarian cancer [ 60 , 61 , 62 , 63 , 64 , 65 ], endometrial cancer [ 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 ], thyroid cancer [ 14 …”